首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1701059

次世代定序仪市场规模、份额、成长分析、按产品、按类型、按技术、按工作流程、按最终用户、按应用、按地区 - 2025 年至 2032 年行业预测

Next Generation Sequencing Market Size, Share, and Growth Analysis, By Offering (Products, Services), By Type (Sequencing Services, Presequencing Services), By Technology, By Workflow, By End User, By Application, By Region - Industry Forecast 2025-2032

出版日期: 2025年04月02日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计 2023 年全球次世代定序仪市场价值将达到 117 亿美元，并从 2024 年的 133.7 亿美元成长到 2032 年的 389.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 14.3%。

下一代定序 (NGS) 是基因组分析领域的一种革命性方法，它利用大规模并行性同时对数百万到数十亿个 DNA 链进行定序，使其比传统的 Sanger 定序更有效率、更具成本效益。 NGS 的优点包括准确度高、结果快速、以及能够从最少的样本量产生准确的数据。该技术已成为生物标记发现、癌症研究、个人化医疗和农业研究等各领域不可或缺的技术。尤其是NGS在了解COVID-19的传播和治疗策略方面发挥关键作用，英国COVID-19基因组学联盟（COG-UK）的努力就是一个例证，该联盟汇集了Welcome Sanger研究所和NHS等组织的资源，透过全基因组定序来分析病毒的进化和传播。

市场概览
定序服务
- EXOME和靶向重测序以及自订面板
- RNA定序
- DE Novo定序
- 晶片测序
- 全基因组序列分析
- 甲基定序
- 其他定序服务
预测序服务
- 文库製备和目标富集
- 样品製备
- 品管
生物资讯学和数据分析服务
- 数据分析
- 数据视觉化与解读
- 资料储存和管理
NGS平台服务

次世代定序仪市场规模（按工作流程和复合年增长率） (2025-2032)

市场概览
顺序
预测序服务
数据分析服务

次世代定序仪市场规模（按最终用户和复合年增长率） (2025-2032)

市场概览
学术研究所
製药和生物技术公司
医院和临床实验室
其他的

次世代定序仪市场规模（按应用和复合年增长率） (2025-2032)

市场概览
诊断
- 癌症诊断
- 感染疾病诊断
- 生殖健康检查
- 其他诊断用途
药物研发
- 药物基因组学
- 其他药物发现与开发应用
农业和动物研究
其他的

次世代定序仪市场规模及复合年增长率（2025-2032）

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业市场定位（2024年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2024年）
主要企业简介
- 公司详情
- 产品系列分析
- 公司分部份额分析
- 收益与前一年同期比较对比（2022-2024 年）
  主要企业简介
  - Illumina公司（美国）
  - 赛默飞世尔科技公司（美国）
  - 珀金埃尔默公司（美国）
  - 华大基因集团（中国）
  - 安捷伦科技公司（美国）
  - Eurofins Scientific SE（卢森堡）
  - 加州太平洋生物科学公司（美国）
  - 牛津奈米孔技术公司（英国）
  - QIAGEN NV（荷兰）
  - F. Hoffmann-La Roche AG（瑞士）
  - Psomagen公司（韩国）
  - 10x Genomics Inc.（美国）

结论和建议

简介目录

Product Code: SQMIG35D2046

Global Next Generation Sequencing Market size was valued at USD 11.7 billion in 2023 and is poised to grow from USD 13.37 billion in 2024 to USD 38.96 billion by 2032, growing at a CAGR of 14.3% during the forecast period (2025-2032).

Next-generation sequencing (NGS) represents a transformative approach in genomic analysis, leveraging massive parallelism to sequence millions to billions of DNA strands simultaneously, making it more efficient and cost-effective compared to traditional Sanger sequencing. NGS's advantages include high accuracy, rapid results, and the capability to generate precise data from minimal sample quantities. This technology has become essential in various fields, including biomarker discovery, cancer research, personalized medicine, and agricultural studies. Notably, NGS has played a critical role in understanding COVID-19 transmission and treatment strategies, exemplified by the efforts of the COVID-19 Genomics U.K. Consortium (COG-U.K.), which combines resources from institutions like the Welcome Sanger Institute and NHS to analyze the virus's evolution and spread through Whole-Genome Sequencing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Next Generation Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Next Generation Sequencing Market Segments Analysis

Global Next Generation Sequencing Market is segmented by Offering, Type, Technology, Workflow, End User, Application and region. Based on Offering, the market is segmented into Products and Services. Based on Type, the market is segmented into Sequencing Services, Presequencing Services, Bioinformatics & Data Analysis Services and NGS Platform Services. Based on Technology, the market is segmented into Sequencing By Synthesis, Ion Semiconductor Sequencing, Smrt Sequencing, Nanopore Sequencing and Other Sequencing Technologies. Based on Workflow, the market is segmented into Sequencing, Presequencing Services and Data Analysis Services. Based on End User, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Laboratories and Other End Users. Based on Application, the market is segmented into Diagnostics, Drug Discovery & Development, Agriculture & Animal Research and Other Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Next Generation Sequencing Market

The Global Next Generation Sequencing (NGS) market is significantly driven by its capability to thoroughly analyze an individual's genome, facilitating the detection of genetic variations. These variations play a crucial role in determining drug responses, disease susceptibility, and potential adverse effects. As a result, this personalized approach is increasingly leading to the integration of NGS in clinical environments, enhancing treatment outcomes by tailoring therapies to align with patients' unique genetic profiles. The ability to offer customized medical solutions not only improves effectiveness but also transforms the future of precision medicine, positioning NGS as a pivotal tool in modern healthcare.

Restraints in the Global Next Generation Sequencing Market

The high costs associated with next-generation sequencing (NGS) procedures, which include sequencing, data analysis, and interpretation, present significant challenges in accessibility for both patients and healthcare providers. The financial burden of purchasing and maintaining NGS technologies limits their application in clinical environments, especially within resource-limited settings. This financial constraint hampers the widespread adoption of NGS, preventing many medical professionals from integrating these advanced sequencing technologies into routine practice. Consequently, the limitations imposed by cost can inhibit advancements in personalized medicine and patient care, underscoring the need for solutions to lower barriers to entry for NGS applications.

Market Trends of the Global Next Generation Sequencing Market

The Global Next Generation Sequencing (NGS) market is experiencing significant growth, driven by its transformative role in diagnosing rare genetic disorders with unparalleled accuracy and speed. As healthcare providers increasingly adopt NGS technologies to sequence genomes, the market is witnessing heightened demand for personalized medicine, early intervention, and optimized management strategies for rare diseases. This trend is further fueled by advancements in NGS platforms, decreasing costs, and enhanced data analysis capabilities, positioning NGS as an indispensable tool in modern genomics and precision healthcare. Consequently, the NGS market is projected to expand robustly, reflecting its critical impact on patient outcomes and healthcare innovation.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Supply Chain Analysis
Patent Analysis
Technology Analysis
Case Studies
Customer And Buying Criteria Analysis
Trade Analysis

Global Next Generation Sequencing Market Size by Offering & CAGR (2025-2032)

Market Overview
Products
Services

Global Next Generation Sequencing Market Size by Type & CAGR (2025-2032)

Market Overview
Consumables
- Library Preparation & And Reagents
- Sequencing Kits & Reagents
- Other Consumables
Platforms
- Sequencing Platforms
- Library Preparation Platforms
Bioinformatics Tools
- Data Analysis Software & Workbenches
- Data Visualization Tools
- Other Bioinformatics Tools

Global Next Generation Sequencing Market Size by Technology & CAGR (2025-2032)

Market Overview
Sequencing By Synthesis
Ion Semiconductor Sequencing
Smrt Sequencing
Nanopore Sequencing
Other Sequencing Technologies

Global Next Generation Sequencing Market Size by Workflow & CAGR (2025-2032)

Market Overview
Sequencing
Presequencing
Data Analysis

Global Next Generation Sequencing Market Size by End User & CAGR (2025-2032)

Market Overview
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Clinical & Diagnostic Laboratories
Other End Users

Global Next Generation Sequencing Market Size by Type & CAGR (2025-2032)

Market Overview
Sequencing Services
- Exome & Targeted Resequencing and Custom Panels
- RNA Sequencing
- DE Novo Sequencing
- Chip Sequencing
- Whole-Genome Sequencing
- Methyl Sequencing
- Other Sequencing Services
Presequencing Services
- Library Preparation & Target Enrichment
- Sample Preparation
- Quality Control
Bioinformatics & Data Analysis Services
- Data Analysis
- Data Visualization & Interpretation
- Data Storage & Management
NGS Platform Services

Global Next Generation Sequencing Market Size by Workflow & CAGR (2025-2032)

Market Overview
Sequencing
Presequencing Services
Data Analysis Services

Global Next Generation Sequencing Market Size by End User & CAGR (2025-2032)

Market Overview
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Clinical Laboratories
Other End Users

Global Next Generation Sequencing Market Size by Application & CAGR (2025-2032)

Market Overview
Diagnostics
- Cancer Diagnostics
- Infectious Disease Diagnostics
- Reproductive Health Diagnostics
- Other Diagnostic Applications
Drug Discovery & Development
- Pharmacogenomics
- Other Drug Discovery & Development Applications
Agriculture & Animal Research
Other Applications

Global Next Generation Sequencing Market Size & CAGR (2025-2032)

North America (Offering, Type, Technology, Workflow, End User, Type, Workflow, End User, Application)
- US
- Canada
Europe (Offering, Type, Technology, Workflow, End User, Type, Workflow, End User, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Offering, Type, Technology, Workflow, End User, Type, Workflow, End User, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Offering, Type, Technology, Workflow, End User, Type, Workflow, End User, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Offering, Type, Technology, Workflow, End User, Type, Workflow, End User, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Illumina Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN NV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Psomagen, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
10x Genomics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments